  |
|
 |
|
Case Report
| ||||||
| Micro invasive papillary thyroid lesion in a post living donor liver transplant patient: A case report | ||||||
| Khaled Abdel wahab1, Essam Attia1, Mohammad Arafa2, Mohamed El Sorogy3, Mohamed Abdel Wahab3 | ||||||
|
1Surgical Oncology Unit, Mansoura Oncology center, Mansoura University.
2Pathology Department, Mansoura University, Egypt. 3Gastroenterology center, Mansoura university, Egypt. | ||||||
| ||||||
|
[HTML Full Text]
[PDF Full Text]
[Print This Article]
[Similar article in Pumed] [Similar article in Google Scholar] 
|
| How to cite this article |
| Wahab KA, Attia E, Arafa M, El Sorogy M, Wahab MA. Micro invasive papillary thyroid lesion in a post living donor liver transplant patient: A case report. Int J Case Rep Imag 2016;7(5):323–326. |
|
Abstract
|
|
Introduction:
Liver transplant recipients are at increased risk of developing de novo malignancies. Skin cancers and lymphoma are common in adult transplant recipients, while post-transplant lymphoproliferative disorder (PTLD) is the most common concern in pediatric transplant recipients. De novo malignancy is a well-recognized complication of solid organ transplantation and associated immunosuppression. The development of such malignancies can be caused by a multifactorial combination of individual and regional predispositions to malignancy, pretransplantation disease states, recipient viral status, and the use and intensity of various immunosuppressive regimens to maintain allografts.
Case Report: This report describes a papillary microinvasion of the thyroid in an adult Egyptian male following liver transplantation and declares the need for a high level of suspicion and careful investigation into any abnormal lesion in the long-term follow-up of solid organ transplant patients. Conclusion: Care should be taken towards any significant symptom or sign suspicious for malignancy for post-transplant patients. The idea of having a routine screening program to detect de novo tumors for those patients should be discussed more. | |
|
Keywords:
De novo malignancy, Immunosuppressive therapy, Liver transplant, Thyroid lesion
| |
|
[HTML Full Text]
[PDF Full Text]
|
|
Author Contributions
Khaled Abdel Wahab – Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published Essam Attia – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published Mohammad Arafa – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published Mohamed El Sorogy – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published Mohamed Abdel Wahab – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published |
|
Guarantor of submission
The corresponding author is the guarantor of submission. |
|
Source of support
None |
|
Conflict of interest
Authors declare no conflict of interest. |
|
Copyright
© 2016 Khaled Abdel Wahab et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information. |
|
|
|
About The Authors
| |||
| |||
| |||
| |||
| |||
| |||
